E. Jennifer Edelman, MD, MHS
Associate Professor of Medicine (General Medicine) and of Social and Behavioral Sciences
Biography
Patient Care
News
Locations
Appointments
Biography
E. Jennifer Edelman, MD, MHS is an Associate Professor of Medicine and Public Health. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as an HIV provider and the physician consultant in the Addiction Medicine Treatment Program at the Yale-New Haven Hospital HIV Clinic. Her research focuses on optimizing HIV prevention and treatment in the context of substance use, including opioid, alcohol and tobacco use. To this end and applying a range of methodologies, she leads and collaborates on NIH-funded projects to evaluate novel and implement evidence-based addiction treatment in medical settings, especially HIV treatment settings. In addition, her work has focused on understanding harms associated with opioid use among people with HIV. She collaborates with community-based and public health partners to promote HIV prevention, including use of pre-exposure prophylaxis (PrEP). She mentors trainees, including post-doctoral fellows and public health students, and is Associate Director of the Research on Addiction Medicine Scholars (RAMS) Program. She regularly serves on NIH grant review committees and is on the editorial board of several peer-reviewed journals.
Education & Training
- Board CertificationAmerican Academy of HIV Medicine, HIV Specialist (2013, recertified: 2021)
- MHSYale University (2012)
- Board CertificationAB of Internal Medicine, Internal Medicine (2009, recertified: 2019)
- Chief ResidentYale-New Haven Hospital (2009)
- ResidencyYale-New Haven Hospital (2008)
- InternYale-New Haven Hospital (2006)
- MDColumbia University (2005)
- BSCornell University, Human Development and Family Studies; and Human Biology, Health (1999)
Activities
- Promoting Emergency Department-Initiated Buprenorphine: What are Barriers and Facilitators among Prescribers?New Haven, United States 2020
- Invited panelist, Examination of Integration of Opioid and Infectious Disease Prevention Efforts in Select ProgramsWashington, United States 2019
- Invited speaker, Adaptive and Integrated Pharmacological Interventions, Stepped CareMinneapolis, United States 2019
- Racial Differences in Alcohol and Other Substance Use among MSM: Implications for HIV PreventionBethesda, United States 2019
- Trajectories of self-reported illicit opioid use among people living with HIVSan Antonio, United States 2019
- Integrated Stepped Care to Address Alcohol Use among Patients Living with HIV and Alcohol Use Disorder: Results from a Randomized Controlled Clinical Trialile.Santiago, Chile 2018
- Unhealthy Alcohol Use among Patients with HIV: Reversing the TrendsMoran, United States 2018
- The Opioid Crisis PanelNew Haven, United States 2018
- Reducing Harms from the Opioid Epidemic: The Role of Pharmacists and Pharmacy TechniciansCromwell, United States 2018
- Trajectories of Non-Medical Use of Prescription Opioids Among People Living With HIVDenver, United States 2018
- Alcohol Behavioral Research and HIV PrEP in Primary CareBethesda, United States 2017
- If You Build It, They Sometimes Come: Use of Integrated Stepped Care Services for Unhealthy Alcohol use in HIV clinicsWashington, United States 2017
- Using Phosphatidylethanol (PEth) to Validate Unhealthy Alcohol Use in Non-Treatment Seeking HIV-Positive Patients Entering Clinical TrialsDenver, United States 2017
- The Impact of Injectable Naltrexone on Antiretroviral Therapy Adherence, HIV Viral Load and Drinking in HIV-Positive Heavy DrinkersDenver, United States 2017
- Do Prescribed Opioids Increase Risk of Community-Acquired Pneumonia Requiring Hospitalization?Washington, United States 2017
- The Prevalence and Impact of Unhealthy Alcohol Use Among Men Who Have Sex With Men Initiating Pre-Exposure Prophylaxis for HIV Infection: A Pilot StudyWashington, United States 2017
- Working with HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?): Initial Lessons LearnedSeattle, United States 2017
- The Opioid Crisis: Where are We and What Can We Do?Toronto, Canada 2016
- Integrated Stepped Care for Unhealthy Alcohol Use in HIV ClinicsLausanne, Switzerland 2016
- Improving PrEP Update: A Need for Implementation ScienceNew York, United States 2016
- Integrating Addiction Treatment and HIV Care: the Role of Implementation ScienceNew York, United States 2016
- Update in HIV Medicine: Turning the Tide on the EpidemicHollywood, United States 2016
- Getting HIV Pre-Exposure Prophylaxis (PrEP) into Primary Care Practice: Train All Providers, Designate an On-Site PrEP Specialist, or Refer Out?Hollywood, United States 2016
- Ending HIV with PrEP: The Newest HIV Prevention Tool for Primary CareHollywood, United States 2016
- Improving HIV Diagnosis and Prevention: The Role of Community-Based Participatory Research PrinciplesSpringfield, United States 2015
- HIV and AlcoholNew Haven, United States 2015
- Hepatitis C and HIV and Opioid Use DisorderNew Haven, United States 2015
- Implementing Integrated Stepped Care for Unhealthy Alcohol Use in HIV Treatment Settings: A Qualitative Study using the CFIR ConstructsWashington, United States 2015
- Implementing Integrated Stepped Care for Unhealthy Alcohol Use in HIV Treatment Settings: A Qualitative Study using the CFIR Constructs.San Antonio, United States 2015
- Do Prescribed Opioids Impact CD4 Count Restoration among HIV-infected Patients Initiating Antiretroviral Therapy?”Phoenix, United States 2015
- Is Opioid Use associated with T Cell Dysfunction?Phoenix, United States 2015
- HIV-Related Stigma and Substance Use in a Russian Cohort of HIV-infected Risky DrinkersPhoenix, United States 2015
- Is Excess Medication associated with Mortality among HIV+ and Uninfected Patients?Toronto, Canada 2015
- Do Prescribed Opioids Impact CD4 Count Restoration among HIV+ Patients Initiating Antiretroviral Therapy?Toronto, Canada 2015
- A Complex Interplay between Social Isolation, Stigma and Substance Use: Results from a Qualitative StudySan Francisco, United States 2015
- Is Unhealthy Alcohol Use Associated with CD4 Cell Count among HIV-infected Patients On and Off Combination Antiretroviral Therapy?Washington, United States 2014
- The Impact of Prescription Opioids on CD4 Count in HIV: A Longitudinal AnalysisSan Juan, Puerto Rico 2014
- Is Unhealthy Alcohol Use Associated with CD4 Cell Count Among HIV-Infected Patients On and Off Combination Antiretroviral Ttherapy?Washington, United States 2014
- Upside and Challenges of Being an Early Career Research Faculty MemberBoston, United States 2013
- HIV+ Individuals on ART Are At Risk of Polypharmacy: More Medication Increases MortalitySan Francisco, United States 2013
- HIV Testing and Sexual Risk Reduction Counseling in Office-Based Buprenrophine/Naloxone TreatmentSan Diego, United States 2013
- HIV updateDenver, United States 2013
- Polypharmacy Among Veterans With and Without HIV Infection in the Veterans Aging Cohort StudyDenver, United States 2013
- Acetaminophen Receipt Among HIV-Infected Patients with Advanced Hepatic FibrosisDenver, United States 2013
- Partner Notification Practices Among HIV-Infected MenDenver, United States 2013
- HIV Status is An Independent Predictor of Receiving Opioid AnalgesicsOrlando, United States 2012
- Improving Partner Notification: A Qualitative Study of Medical Case Managers,Disease Intervention Specialists and Men Who Have Sex With MenOrlando, United States 2012
- The Impact of Buprenorphine/Naloxone Treatment on HIV Risk Behaviors Among HIV-Infected, Opioid-Dependent Patients: Results From the BHIVES CollaborationOrlando, United States 2012
- Partner Notification: A Qualitative Study of Medical Case Managers, Disease Intervention Specialists and Men Who Have Sex With MenMinneapolis, United States 2012
- Project COACH: Counseling Others About Contacts and Exposures with HIVWashington, United States 2011
- Project ART-ED: Alcohol reduction and HIV testing in the Emergency DepartmentBoston, United States 2011
- Prescription Opioids Among HIV-Infected and Uninfected VeteransWashington, United States 2011
- Project ART-ED: Alcohol Reduction and HIV Testing in the Emergency DepartmentPhoenix, United States 2011
- Symptoms on EFV/FTC/TDF vs. Other cART Regimens”Phoenix, United States 2011
- Symptoms on Atripla vs. Other cARTAtlanta, United States 2010
- Patient and Provider-Reported Symptoms in the cART EraMinneapolis, United States 2010
- Opiates for Chronic Pain: A Rational Approach for the Primary Care ProviderProvidence, United States 2010
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Locally-Initiated Project Funding Award: “Prescription Opioid Tapering: Trajectories Among Men and Women Veterans” | Veterans Affairs | 2019 |
| Award for Excellence in Clinical Investigation | New England Society of General Internal Medicine (SGIM) | 2018 |
| Research Award: “Optimizing HIV Prevention Among MSM Prescribed PrEP with Heavy Alcohol Use: A qualitative study to examine acceptability of ‘PrEP-STEPs" | Fund for Lesbian and Gay Studies (FLAGS) | 2018 |
| Best Reviewer | Annals of Internal Medicine | 2018 |
| Best Reviewer | Pharmacoepidemiology and Drug Safety | 2016 |
| Editorial Fellowship | Journal of Substance Abuse Treatment | 2015 |
| Early Career Investigator Travel Award (to the 2014 College on Problems of Drug Dependence Annual Meeting) | National Institute on Drug Abuse (NIH) | 2014 |
| Travel Award (to the 8th International Annual INEBRIA Conference) | National Institute on Drug Abuse (NIH) | 2011 |
| Lawrence Linn Award | Society of General Internal Medicine | 2010 |
| Frederick L. Sachs Award | Frederick L. Sachs | 2008 |
| Humanism in Medicine Award | Leonard Tow | 2005 |
| Glasgow-Rubin Achievement Award | American Medical Women's Association (AMWA) | 2005 |
| Honor Society Member | Alpha Omega Alpha Honor Society | 2005 |
| Honor Society Member | Arnold P. Gold Humanism in Medicine Honor Society | 2005 |
| Dr. Robert A. Savitt & Dr. George D. McCormack Award | Dr. Robert A. Savitt & Dr. George D. McCormack | 2005 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Health Services and Research Core | Director | 2020 - Present |
| Special Emphasis Panel Review Committee for Member Conflicts for AIDS and Related Research | Reviewer | 2020 - Present |
| Yale Physician Associate Program Thesis Readers’ Committee | Committee Member | 2019 |
| Healthcare Deliveries and Methodologies Member Conflict Study Section, NIH/Center for Scientific Research. | Reviewer | 2019 |
| Special Emphasis Panel Review Committee for “PAR18-222: Multi-site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01)” and “PAR18-223: Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services" | Reviewer | 2019 |
| Special Emphasis Panel Review Committee for “RFA-DA-19-013: Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA Funding” | Reviewer | 2019 |
| Journal of General Internal Medicine, Deputy Editor | Editor | 2019 - Present |
| Society of General Internal Medicine, Best Paper, National Annual Meeting | Reviewer | 2018 - 2020 |
| “PAR-16-055: Mechanism for Time-Sensitive Drug Abuse Research (R21),” NIH/NIDA | Reviewer | 2018 |
| American Academy of HIV Medicine New England Steering Committee | Member | 2018 - Present |
| Data and Safety Monitoring Board, Yale Psychotherapy Development Center | Board Member | 2017 - 2020 |
| Yale Physician Associate Program Thesis Readers’ Committee | Committee Member | 2017 |
| Special Emphasis Panel for “Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)”, NIH/NIDA | Reviewer | 2017 |
| Special Emphasis Panel for “HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)”, NIH/NIDA | Reviewer | 2017 |
| Veterans Health Administration, Sexually Transmitted Infections (STI) Screening and Resources for the Primary Care of Veterans with HIV Manual | Reviewer | 2017 |
| Addiction Science and Clinical Practice | Associate Editor | 2017 - Present |
| Addiction Science and Clinical Practice, Special Issue Co-Editor | Editor | 2017 - Present |
| American College of Physicians, American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder | Reviewer | 2017 - Present |
| Yale University Traditional Medicine Residency Program, MAC (Mentor, Advisor, Coach) for Residents | Mentor | 2016 - 2020 |
| Journal of Substance Abuse Treatment, Editorial Board Member | Editor | 2016 - Present |
| College on Problems of Drug Dependence | Member | 2016 - Present |
| Journal of Substance Abuse Treatment, Editorial Fellow | Editor | 2015 - 2016 |
| Special Emphasis Panel for “Centers for AIDS Research and Developmental Centers for AIDS Research”, NIH/NIAID | Reviewer | 2014 |
| Infectious Disease Society, 2014 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Infected with HIV | Reviewer | 2014 |
| Polypharmacy Workgroup, Veterans Aging Cohort Study, Yale University/West Haven VA Connecticut Healthcare System | Co-Chair | 2013 - 2019 |
| Society of General Internal Medicine, HIV Interest Group | Co-Chair | 2013 - 2019 |
| Yale Physician Associate Program Thesis Readers’ Committee | Committee Member | 2013 |
| Special Emphasis Panel for “Clinical Trials Units for NIAID Networks (UM1)”, NIH/NIAID | Reviewer | 2013 |
| Pilot Project Review Committee, Center for Interdisciplinary Research on AIDS, Yale University | Reviewer | 2013 |
| Society of General Internal Medicine, New England Regional Annual Meeting, Abstract Reviewer | Reviewer | 2013 - Present |
| Yale University Traditional Medicine Residency Program, Intern Selection Committee | Committee Member | 2012 - 2017 |
| Society of General Internal Medicine, National Annual Meeting, Abstract Reviewer | Reviewer | 2012 - 2016 |
| Community Research Partnership Program Grant Review Committee, Center for Interdisciplinary Research on AIDS, Yale University | Reviewer | 2012 |
| AIDS Project New Haven, City of New Haven | Board Member | 2012 - Present |
| Society of General Internal Medicine, Alcohol, Tobacco, and Other Drug (ATOD) Use Interest Group | Member | 2012 - Present |
| Ryan White FY2011 Proposal Review Committee | Member | 2011 |
| Opioids Workgroup, Veterans Aging Cohort Study, Yale University/West Haven VA Connecticut Healthcare System | Co-Chair | 2011 - Present |
| CT HIV/AIDS Identification and Referral Task Force | Member | 2010 - 2018 |
| Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Community Research Implementation Core | Member | 2010 - Present |
| Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Health Services and Research Core | Member | 2010 - Present |
| Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Workgroup, Multi-level HIV Intervention Network Trial (MHINT) | Develop the clinical improvement and interventions | 2009 - 2010 |
Departments & Organizations
- Addiction Medicine Fellowship Program
- AIDS Care Program
- Drug use, Addiction, and HIV Research Scholars (DAHRS)
- General Internal Medicine
- Internal Medicine
- Office of Cooperative Research
- Program in Addiction Medicine
- Yale Center for Health & Learning Games
- Yale Medicine
- Yale School of Public Health
- Yale University
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative